Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
European Journal of Gastroenterology & Hepatology|January 3, 2020
Herbal medicines for the liver: from bench to bedsideEduardo E Vargas-Pozada, Pablo Muriel
International Journal of Molecular Sciences|March 28, 2026
Potential Therapeutic Strategies for Steatosis, Oxidative Stress, Inflammation, and Fibrosis in Liver DiseasePablo Muriel, Eduardo E Vargas-Pozada, Linda Vanessa Márquez-Quiroga, et al.
European Journal of Gastroenterology & Hepatology|March 26, 2023
Mechanisms of non-alcoholic fatty liver disease development in normal-weight individualsPablo Muriel, Irina Cardoso-Lezama, Eduardo E Vargas-Pozada, et al.
Biochemical Pharmacology|September 17, 2025
Coffee for the liver: a mechanistic approachEduardo E Vargas-Pozada, Erika Ramos-Tovar, Linda Vanessa Márquez-Quiroga, et al.
Canadian Journal of Physiology and Pharmacology|February 6, 2023
The antioxidant and anti-inflammatory activities of caffeine effectively attenuate nonalcoholic steatohepatitis and thioacetamide-induced hepatic injury in male ratsEduardo E Vargas-Pozada, Erika Ramos-Tovar, Consuelo Acero-Hernández, et al.
Annals of Hepatology|January 22, 2022
Caffeine mitigates experimental nonalcoholic steatohepatitis and the progression of thioacetamide-induced liver fibrosis by blocking the MAPK and TGF-β/Smad3 signaling pathwaysEduardo E Vargas-Pozada, Erika Ramos-Tovar, Consuelo Acero-Hernández, et al.
Toxicology Mechanisms and Methods|August 2, 2023
Serum α-SMA is a potential noninvasive biomarker of liver fibrosisIrina Cardoso-Lezama, Erika Ramos-Tovar, Jaime Arellanes-Robledo, et al.
Toxicology Mechanisms and Methods|July 1, 2025
Chronological activation of the NLRP3 inflammasome/pyroptosis pathway in the progression from metabolic dysfunction-associated fatty liver disease to hepatocellular carcinomaLinda Vanessa Márquez-Quiroga, Eduardo E Vargas-Pozada, Irina Cardoso-Lezama, et al.
Biochemical Pharmacology|August 21, 2023
Nicotinic acid attenuates experimental non-alcoholic steatohepatitis by inhibiting the NLRP3 inflammasome/pyroptosis pathwayIrina Cardoso-Lezama, Miguel Á Fuentes-Figueroa, Erika Ramos-Tovar, et al.
Annals of Hepatology|October 29, 2022
Activation of the NLRP3 inflammasome by CCl4 exacerbates hepatopathogenic diet-induced experimental NASHEduardo E Vargas-Pozada, Erika Ramos-Tovar, Juan D Rodriguez-Callejas, et al.
Pageof 2